Pilgrim Partners Asia Pte Ltd Buys Shares of 31,600 agilon health, inc. (NYSE:AGL)

Pilgrim Partners Asia Pte Ltd acquired a new stake in shares of agilon health, inc. (NYSE:AGL) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 31,600 shares of the company’s stock, valued at approximately $60,000.

A number of other large investors have also made changes to their positions in the company. Symphony Financial Services Inc. grew its stake in agilon health by 44.3% in the fourth quarter. Symphony Financial Services Inc. now owns 23,000 shares of the company’s stock valued at $44,000 after purchasing an additional 7,058 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of agilon health in the third quarter worth $28,000. Signaturefd LLC boosted its holdings in shares of agilon health by 143.0% in the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock valued at $27,000 after purchasing an additional 8,467 shares in the last quarter. Oak Thistle LLC acquired a new stake in agilon health in the fourth quarter valued at approximately $25,000. Finally, Ieq Capital LLC bought a new stake in shares of agilon health during the fourth quarter worth about $26,000.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on AGL shares. Macquarie initiated coverage on shares of agilon health in a research note on Monday, December 16th. They set a “neutral” rating and a $3.00 target price for the company. Stifel Nicolaus upped their price objective on shares of agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a research report on Wednesday, February 26th. Sanford C. Bernstein increased their price objective on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a report on Wednesday, January 15th. Royal Bank of Canada boosted their price objective on agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research note on Wednesday, February 26th. Finally, Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research note on Friday, March 21st. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, agilon health presently has an average rating of “Hold” and an average price target of $3.95.

agilon health Stock Performance

Shares of NYSE:AGL opened at $4.14 on Friday. agilon health, inc. has a 52 week low of $1.50 and a 52 week high of $7.73. The firm has a 50 day moving average of $3.74 and a 200 day moving average of $3.00. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $1.70 billion, a price-to-earnings ratio of -4.40 and a beta of 0.38.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.